全球羊膜穿刺针市场规模、份额、趋势和成长分析报告（2026-2034年）

预计羊膜穿刺针市场将从 2025 年的 2.4094 亿美元成长到 2034 年的 4.5655 亿美元，2026 年至 2034 年的复合年增长率为 7.36%。

由于遗传疾病盛行率不断上升以及全球孕妇年龄增长，全球羊膜穿刺术市场正经历稳定成长。羊膜穿刺术广泛用于产前诊断染色体异常和遗传疾病。人们对早期发现胎儿异常重要性的认识不断提高，以及产前筛检技术的进步，都大大推动了已开发国家和开发中国家的市场扩张。

关键成长要素包括对微创产前诊断程序的需求增加，以及针头设计的改进提高了安全性和准确性。医疗基础设施的进步和诊断检查室数量的增加也促进了需求成长。此外，政府对推广产前健康检查计画的支持也对市场成长产生了积极影响。

在持续的技术创新推动下，检测的未来前景仍然光明，这些创新旨在降低与检测相关的风险。超音波引导技术的整合以及病患安全通讯协定的改进将加速该技术的普及。新兴经济体产前保健服务的普及和对早期基因检测日益增长的重视，预计将在未来几年推动该技术的持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球羊膜穿刺针市场：依类型划分

• 市场分析、洞察与预测
• 100～150mm
• 小于100毫米
• 超过150毫米

第五章：全球羊膜穿刺针市场：依手术类型划分

• 市场分析、洞察与预测
• 羊膜穿刺术
• 羊水减重治疗
• 胎儿输血
• 羊水输注程序
• 脐带穿刺术

第六章：全球羊膜穿刺针市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 诊所
• 其他的

第七章 全球羊膜穿刺针市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Smiths Medical
  • Biopsybell Srl
  • Integra LifeSciences
  • Laboratoire CCD
  • Cook Medical
  • RI.MOS. Srl
  • CooperSurgical
  • Medline
  • Rocket Medical
  • Becton Dickinson And Company

The Amniocentesis Needle Market size is expected to reach USD 456.55 Million in 2034 from USD 240.94 Million (2025) growing at a CAGR of 7.36% during 2026-2034.

The Global Amniocentesis Needle Market is witnessing steady growth due to the increasing prevalence of genetic disorders and rising maternal age worldwide. Amniocentesis procedures are widely performed for prenatal diagnosis of chromosomal abnormalities and inherited conditions. Growing awareness about early detection of fetal anomalies and advancements in prenatal screening technologies are significantly supporting market expansion across developed and developing regions.

Key growth drivers include rising demand for minimally invasive prenatal diagnostic procedures and improvements in needle design that enhance safety and precision. Increasing healthcare infrastructure development and the growing number of diagnostic laboratories are also contributing to demand. Additionally, supportive government initiatives promoting maternal health screening programs are positively influencing market growth.

Future prospects remain promising with continuous technological advancements aimed at reducing procedure-related risks. Integration of ultrasound-guided techniques and improved patient safety protocols will enhance adoption. Expanding access to prenatal care in emerging economies and increasing focus on early genetic testing are expected to drive sustained growth over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• 100 to 150 mm
• Smaller Than 100 mm
• Larger Than 150 mm

By Procedure

• Amniocentesis Procedures
• Amnioreduction Procedures
• Fetal Blood Transfusion
• Amnioinfusion Procedure
• Cordocentesis Procedure

By End-use

• Hospitals
• Diagnostics Centers
• Clinics
• Others

COMPANIES PROFILED

• Smiths Medical, Biopsybell Srl, Integra LifeSciences, Laboratoire CCD, Cook Medical, RIMOS Srl, CooperSurgical, Medline, Rocket Medical, Becton Dickinson and Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. 100 to 150 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Smaller Than 100 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Larger Than 150 mm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Amniocentesis Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Amnioreduction Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fetal Blood Transfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Amnioinfusion Procedure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Cordocentesis Procedure Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AMNIOCENTESIS NEEDLE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Procedure
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Procedure
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Procedure
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Procedure
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Procedure
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AMNIOCENTESIS NEEDLE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Smiths Medical
  • 9.2.2 Biopsybell Srl
  • 9.2.3 Integra LifeSciences
  • 9.2.4 Laboratoire CCD
  • 9.2.5 Cook Medical
  • 9.2.6 RI.MOS. Srl
  • 9.2.7 CooperSurgical
  • 9.2.8 Medline
  • 9.2.9 Rocket Medical
  • 9.2.10 Becton Dickinson And Company